S Lv,
L Ji, B Chen, S Liu, C Lei, X Liu, X Qi, Y Wang… - Oncogene, 2018 - nature.com
Abnormalities in epigenetic modifiers are emerging as driving events in prostate cancer
(PCa). The histone methyltransferase KMT2D, a frequently aberrant epigenetic modifier in …